Article Text
Abstract
1. (c) is false
Overweight patients like this man with pain, are more likely than matched, non-neuropathy controls, to show impaired glucose tolerance (see Hughes et al. in Brain 2004, 127, 1723–30). This is less likely when the neuropathy is painless. Impaired glucose tolerance is usually defined by glucose levels of 7.8–11 mmol/L 2 hours after a 75g oral glucose load. The fasting insulin concentration is also likely to be elevated. After adjusting for body mass index, hypertriglyceridaemia not linked to diabetes mellitus, is more likely in patients than controls, suggesting a ‘metabolic’ basis to chronic axonal polyneuropathy, which is not a direct consequence of hyperglycaemia per se.
2. (a) and (d) are true
Information on pergolide associated valvular heart disease is evolving. A high prevalence (> 40%) of ‘serious’ valve disease has recently been described in an echocardiographic case-control study (Neurology 2004, 63, 301–4). It seems
Statistics from Altmetric.com
Read the full text or download the PDF:
Other content recommended for you
- Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study
- Prevalence of peripheral neuropathy in pre-diabetes: a systematic review
- How Good at Neurology are you? – Questions
- Investigation of peripheral neuropathy
- Painful diabetic neuropathy
- Diagnosis and management of sensory polyneuropathy
- Additional causes for distal sensory polyneuropathy in diabetic patients
- Post-challenge hyperinsulinaemia rather than hyperglycaemia is associated with the severity of coronary artery disease in patients without a previous diagnosis of diabetes mellitus
- Insulin resistance, beta-cell function, adipokine profiles and cardiometabolic risk factors among Chinese youth with isolated impaired fasting glucose versus impaired glucose tolerance: the BCAMS study
- Diabetic neuropathy